Tommaso Porcelli Francesca Sessa Angela Caputo Christian Catalini Domenico Salvatore
10.3389/fendo.2018.00244
Front Endocrinol (Lausanne)
2018 May 17;9:244.
lenvatinib metastatic thyroid cancer postsurgical hypoparathyroidism recombinant human parathyroid hormone (1–34) targeted therapy teriparatide tyrosine kinase inhibitors
CC BY
https://pubmed.ncbi.nlm.nih.gov/29867775/
Case Reports
PMC5966541
29867775
Teriparatide Replacement Therapy for Hypoparathyroidism During Treatment With Lenvatinib for Advanced Thyroid Cancer: A Case Report
2018